APPLICATION
ANDA088974
TYPE
ANDA
ORIGINAL APPROVAL
1985-07-22
LATEST ACTION
2003-01-06
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 500MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2003-01-06Manufacturing (CMC) · Supplement 20AP
2002-12-09Manufacturing (CMC) · Supplement 23AP
2002-12-09Manufacturing (CMC) · Supplement 21AP
2002-12-09Manufacturing (CMC) · Supplement 22AP
2002-03-22Manufacturing (CMC) · Supplement 17AP
2002-03-13Labeling · Supplement 19AP
2002-01-04Labeling · Supplement 18AP
2001-04-02Manufacturing (CMC) · Supplement 16AP
1999-06-17Manufacturing (CMC) · Supplement 15AP
1999-03-23Manufacturing (CMC) · Supplement 14AP
1998-06-11Manufacturing (CMC) · Supplement 13AP
1996-05-31Manufacturing (CMC) · Supplement 12AP
1995-06-23Labeling · Supplement 11AP
1994-08-02Manufacturing (CMC) · Supplement 10AP
1991-11-13Labeling · Supplement 9AP
1991-08-09Labeling · Supplement 8AP
1989-04-06Labeling · Supplement 7AP
1986-07-25Manufacturing (CMC) · Supplement 6AP
1986-07-25Manufacturing (CMC) · Supplement 4AP
1985-11-18Manufacturing (CMC) · Supplement 1AP
1985-07-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.